Type | Sym | Class | Transaction | Value $ | Shares | Change % | * Price $ | Shares After | Date | Ownership | Footnotes |
---|---|---|---|---|---|---|---|---|---|---|---|
transaction | HUMA | Common Stock | Sale | -$12.7M | -4.88M | -31.73% | $2.60 | 10.5M | Jun 13, 2023 | By Ayabudge LLC | F1 |
holding | HUMA | Common Stock | 1.27M | Jun 13, 2023 | Direct | ||||||
holding | HUMA | Common Stock | 510K | Jun 13, 2023 | By spouse |
Id | Content |
---|---|
F1 | The sales were made by Ayabudge LLC, an entity controlled by Brady W. Dougan. The transactions enabled Mr. Dougan to pay down leverage while providing a mechanism for the institutional healthcare investor purchasers to acquire shares of the Issuer at a time that the Issuer was not conducting a financing transaction and was not making any additional shares available for purchase. Dr. Niklason is treated as indirectly beneficially owning the shares sold, resulting in the requirement to file this Form 4. However, no shares directly owned by Dr. Niklason were sold in these transactions. |